MX2024007863A - Uso de compuestos de aminopirazol. - Google Patents
Uso de compuestos de aminopirazol.Info
- Publication number
- MX2024007863A MX2024007863A MX2024007863A MX2024007863A MX2024007863A MX 2024007863 A MX2024007863 A MX 2024007863A MX 2024007863 A MX2024007863 A MX 2024007863A MX 2024007863 A MX2024007863 A MX 2024007863A MX 2024007863 A MX2024007863 A MX 2024007863A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- aminopyrazole compounds
- jak
- aminopyrazole
- atopic
- Prior art date
Links
- JVVRJMXHNUAPHW-UHFFFAOYSA-N 1h-pyrazol-5-amine Chemical class NC=1C=CNN=1 JVVRJMXHNUAPHW-UHFFFAOYSA-N 0.000 title 1
- 201000008937 atopic dermatitis Diseases 0.000 abstract 2
- 206010012434 Dermatitis allergic Diseases 0.000 abstract 1
- 206010012438 Dermatitis atopic Diseases 0.000 abstract 1
- 229940122245 Janus kinase inhibitor Drugs 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 102100033438 Tyrosine-protein kinase JAK1 Human genes 0.000 abstract 1
- 101710112793 Tyrosine-protein kinase JAK1 Proteins 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21217736 | 2021-12-24 | ||
| PCT/EP2022/087698 WO2023118555A1 (en) | 2021-12-24 | 2022-12-23 | Use of aminopyrazole compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024007863A true MX2024007863A (es) | 2024-08-30 |
Family
ID=79025165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024007863A MX2024007863A (es) | 2021-12-24 | 2022-12-23 | Uso de compuestos de aminopirazol. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250049775A1 (https=) |
| EP (1) | EP4452970A1 (https=) |
| JP (1) | JP2024545293A (https=) |
| KR (1) | KR20240124925A (https=) |
| CN (1) | CN118541364A (https=) |
| AU (1) | AU2022418280A1 (https=) |
| CA (1) | CA3242449A1 (https=) |
| MX (1) | MX2024007863A (https=) |
| WO (1) | WO2023118555A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4208157A1 (en) | 2020-09-04 | 2023-07-12 | Elanco Us Inc. | Palatable formulations |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK286640B6 (sk) | 1998-06-19 | 2009-03-05 | Pfizer Products Inc. | Pyrol [2,3-d] pyrimidínová zlúčenina, jej použitie na výrobu liečiva, farmaceutická kompozícia s jej obsahom, použitie jej kombinácie s ďalšími činidlami a súpravy s jej obsahom na výrobu liečiva |
| KR101335843B1 (ko) | 2008-08-20 | 2013-12-02 | 조에티스 엘엘씨 | 피롤로[2,3-ｄ]피리미딘 화합물 |
| CA2849168A1 (en) | 2011-09-22 | 2013-03-28 | Merck Sharp & Dohme Corp. | Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors |
| WO2014146246A1 (en) | 2013-03-19 | 2014-09-25 | Merck Sharp & Dohme Corp. | Cycloalkyl nitrile pyrazolo pyridones as janus kinase inhibitors |
| JP7116063B2 (ja) | 2016-12-14 | 2022-08-09 | インターベット インターナショナル ベー． フェー． | 選択的ヤヌスキナーゼ阻害剤としてのアミノピラゾール類 |
| KR20220119024A (ko) * | 2019-12-20 | 2022-08-26 | 인터벳 인터내셔널 비.브이. | 피라졸 제약 조성물 |
-
2022
- 2022-12-23 CN CN202280084861.5A patent/CN118541364A/zh active Pending
- 2022-12-23 WO PCT/EP2022/087698 patent/WO2023118555A1/en not_active Ceased
- 2022-12-23 MX MX2024007863A patent/MX2024007863A/es unknown
- 2022-12-23 CA CA3242449A patent/CA3242449A1/en active Pending
- 2022-12-23 JP JP2024537401A patent/JP2024545293A/ja active Pending
- 2022-12-23 KR KR1020247020622A patent/KR20240124925A/ko active Pending
- 2022-12-23 US US18/721,916 patent/US20250049775A1/en active Pending
- 2022-12-23 AU AU2022418280A patent/AU2022418280A1/en active Pending
- 2022-12-23 EP EP22844123.4A patent/EP4452970A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023118555A1 (en) | 2023-06-29 |
| KR20240124925A (ko) | 2024-08-19 |
| EP4452970A1 (en) | 2024-10-30 |
| AU2022418280A1 (en) | 2024-06-13 |
| US20250049775A1 (en) | 2025-02-13 |
| CN118541364A (zh) | 2024-08-23 |
| JP2024545293A (ja) | 2024-12-05 |
| CA3242449A1 (en) | 2023-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2022002413A2 (es) | Composiciones y métodos para tratar la psoriasis y la dermatitis atópica usando prevotella histicola | |
| DOP2018000226A (es) | Nuevos derivados de pirazolopirimidina | |
| CO2019007863A2 (es) | Derivados de benzooxazol como inmunomoduladores | |
| CO2018007528A2 (es) | Compuestos heterocíclicos como inmunomoduladores | |
| DOP2019000110A (es) | 1,2,4triazolonas 2,4,5trisustituidas | |
| DOP2019000206A (es) | 2-heteroaril-3-oxo-2,3-dihidropiridazin-4-carboxamidas | |
| CL2018003701A1 (es) | Compuestos heterocíclicos como inmunomoduladores. | |
| MX390535B (es) | Compuestos de amino-triazolopiridina y su uso en el trataniento del cancer. | |
| ECSP18083519A (es) | Inhibidores de bromodominios | |
| CL2017003073A1 (es) | Inhibidores de tirosina-cinasas | |
| ECSP14013148A (es) | Derivados de azetidinil fenil, piridil o pirazinil carboxamida como inhibidores de jak | |
| CL2019000304A1 (es) | Fracciones de plasma en sangre como tratamiento para tratamientos cognitivos relacionados con el envejecimiento. | |
| UY37460A (es) | 1,2,4-triazolonas con anelación en 4 y 5 | |
| CL2018001569A1 (es) | Compuestos heteroaromáticos como inhibidores de btk | |
| CL2019000476A1 (es) | Compuestos de heteroarilcarboxamida como inhibidores de ripk2. | |
| CU24608B1 (es) | Compuestos de dihidrooxadiazinonas sustituidas útiles en el tratamiento de enfermedades hiperproliferativas y métodos para preparar dichos compuestos | |
| CL2019001091A1 (es) | Tratamientos de combinación que comprenden la administración de imidazopirazinonas. | |
| CL2021001656A1 (es) | Compuestos de imidazopiridina e imidazopiridina y sus usos. | |
| CL2020001107A1 (es) | Novedosos derivados de pirazolo-pirrolo-pirimidina como inhibidores de p2x3. | |
| NI201801172A (es) | Nuevos compuestos para el tratamiento de enfermedades parasitarias | |
| MX2024013040A (es) | Pirfenidona enriquecida con deuterio y metodos para su uso | |
| UY36070A (es) | Triterpenoides con actividad inhibidora de la maduración de hiv | |
| MX2021005535A (es) | Compuestos antibióticos, métodos de fabricacion de los mismos, composiciones farmacéuticas contienendo los mismos y usos de los mismos. | |
| CO2020001506A2 (es) | Nuevos compuestos | |
| MX2024007863A (es) | Uso de compuestos de aminopirazol. |